Profil national des indicateurs d’alerte précoce de la pharmaco-résistance du VIH au Cameroun

INTRODUCTION : since the launch of the “Treatment for All in Cameroon” strategy in 2015, an acceleration plan for antiretroviral (ARV) therapy in Cameroon was implemented, with remarkable progresses. These efforts were accompanied by the risk of developing HIV drug resistance. Then, the World Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Billong, Serge Clotaire, Fokam, Joseph, Penda, Calixte Ida, Mvilongo, Ernest Anaba, Fodjo, Raoul, Messeh, Arlette, Anoubissie, Jean de Dieu, Kegne, Cyprien, Nguekam, Gildas, Batamack, Yannick Aimé, Billong, Edson Joan, Moutapam, Pamela Reine, Ndjolo, Alexis, Bonono, Leonard, Elat, Jean Bosco, Bissek, Anne Cécilé Zoung-Kanyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992409/
https://www.ncbi.nlm.nih.gov/pubmed/33796187
http://dx.doi.org/10.11604/pamj.2020.37.374.17649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992409/
https://www.ncbi.nlm.nih.gov/pubmed/33796187
http://dx.doi.org/10.11604/pamj.2020.37.374.17649

Ejemplares similares